Teladoc Health, Inc. (TDOC)
Total Valuation
Teladoc Health has a market cap or net worth of $2.54 billion. The enterprise value is $3.00 billion.
Market Cap | 2.54B |
Enterprise Value | 3.00B |
Important Dates
The next estimated earnings date is Wednesday, April 24, 2024, after market close.
Earnings Date | Apr 24, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Teladoc Health has 167.04 million shares outstanding. The number of shares has increased by 1.93% in one year.
Shares Outstanding | 167.04M |
Shares Change (YoY) | +1.93% |
Shares Change (QoQ) | +0.58% |
Owned by Insiders (%) | 0.79% |
Owned by Institutions (%) | 75.85% |
Float | 165.53M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 357.14 |
PS Ratio | 0.97 |
Forward PS | 0.93 |
PB Ratio | 1.09 |
P/FCF Ratio | 13.10 |
PEG Ratio | -1.01 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.45, with an EV/FCF ratio of 15.47.
EV / Earnings | n/a |
EV / Sales | 1.15 |
EV / EBITDA | 19.45 |
EV / EBIT | n/a |
EV / FCF | 15.47 |
Financial Position
The company has a current ratio of 3.54, with a Debt / Equity ratio of 0.68.
Current Ratio | 3.54 |
Quick Ratio | 3.19 |
Debt / Equity | 0.68 |
Debt / EBITDA | 10.27 |
Debt / FCF | 8.17 |
Interest Coverage | -8.86 |
Financial Efficiency
Return on equity (ROE) is -9.60% and return on invested capital (ROIC) is -6.36%.
Return on Equity (ROE) | -9.60% |
Return on Assets (ROA) | -5.10% |
Return on Capital (ROIC) | -6.36% |
Revenue Per Employee | $464,717 |
Profits Per Employee | -$39,351 |
Employee Count | 5,600 |
Asset Turnover | 0.60 |
Inventory Turnover | 17.70 |
Taxes
In the past 12 months, Teladoc Health has paid $760,000 in taxes.
Income Tax | 760,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -37.75% in the last 52 weeks. The beta is 0.94, so Teladoc Health's price volatility has been similar to the market average.
Beta (1Y) | 0.94 |
52-Week Price Change | -37.75% |
50-Day Moving Average | 17.57 |
200-Day Moving Average | 20.35 |
Relative Strength Index (RSI) | 42.27 |
Average Volume (30 Days) | 4,688,540 |
Short Selling Information
The latest short interest is 21.60 million, so 12.93% of the outstanding shares have been sold short.
Short Interest | 21.60M |
Short Previous Month | 19.23M |
Short % of Shares Out | 12.93% |
Short % of Float | 13.05% |
Short Ratio (days to cover) | 3.67 |
Income Statement
In the last 12 months, Teladoc Health had revenue of $2.60 billion and -$220.37 million in losses. Loss per share was -$1.34.
Revenue | 2.60B |
Gross Profit | 1.84B |
Operating Income | -248.55M |
Pretax Income | -219.61M |
Net Income | -220.37M |
EBITDA | 154.00M |
EBIT | -197.33M |
Loss Per Share | -$1.34 |
Balance Sheet
The company has $1.12 billion in cash and $1.58 billion in debt, giving a net cash position of -$457.85 million or -$2.74 per share.
Cash & Cash Equivalents | 1.12B |
Total Debt | 1.58B |
Net Cash | -457.85M |
Net Cash Per Share | -$2.74 |
Equity / Book Value | 2.33B |
Book Value Per Share | 13.93 |
Working Capital | 1.07B |
Cash Flow
In the last 12 months, operating cash flow was $350.02 million and capital expenditures -$156.35 million, giving a free cash flow of $193.67 million.
Operating Cash Flow | 350.02M |
Capital Expenditures | -156.35M |
Free Cash Flow | 193.67M |
FCF Per Share | $1.18 |
Margins
Gross margin is 70.80%, with operating and profit margins of -9.55% and -8.47%.
Gross Margin | 70.80% |
Operating Margin | -9.55% |
Pretax Margin | -8.44% |
Profit Margin | -8.47% |
EBITDA Margin | 5.92% |
EBIT Margin | -7.58% |
FCF Margin | 7.44% |
Dividends & Yields
Teladoc Health does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.93% |
Shareholder Yield | -1.93% |
Earnings Yield | -8.69% |
FCF Yield | 7.63% |
Analyst Forecast
The average price target for Teladoc Health is $23.21, which is 51.21% higher than the current price. The consensus rating is "Buy".
Price Target | $23.21 |
Price Target Difference | 51.21% |
Analyst Consensus | Buy |
Analyst Count | 14 |
Revenue Growth Forecast (5Y) | 7.16% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Teladoc Health has an Altman Z-Score of -3.38 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -3.38 |
Piotroski F-Score | 5 |